Product Name | N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-3-hydroxyphenyl)cyclopropane-1,1-dicarboxamide |
Synonyms | Cabozantinib impurity 66;F5HE6AB5AL;Cabozantinib metabolite M13;BDBM381928;US10273211, Compound 13;1,1-Cyclopropanedicarboxamide, N-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(4-fluoro-3-hydroxyphenyl)-;N-(4-((6,7-Dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide;Unii-F5HE6AB5AL |
Catalog No. | H-047446 |
CAS No. | 1628530-41-5 |
Molecular Formula | C28H24FN3O6 |
Molecular Weight | 517.5051 |
Smile Code | O=C(C1(C(N)=O)CC1)N(C2=CC=C(OC3=CC=NC4=CC(OC)=C(OC)C=C34)C=C2)C5=CC=C(F)C(O)=C5 |
InChI | |
EINECS | |
Density | |
Melting point | |
Boiling point | |
Refractive index | |
Water solubility | |
Hazard Symbols | |
Risk Codes | |
Safety Description |